Ocugen Latest News: What OCGN Stock Investors Need to Know About the FDA’s Covaxin Rejection
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
Ocugen (OCGN) stock is falling hard on Friday after the FDA rejected its Emergency Use Authorization request for Covaxin.
The post Ocugen Latest News: What OCGN Stock Investors Need to Know About the FDA’s Covaxin Rejection appeared first on InvestorPlace.
More From InvestorPlace- Get in Now on Tiny $3 ‘Forever Battery’ Stock
- It doesn’t matter if you have $500 in savings or $5 million. Читать дальше...